Adverse outcome of coarctation stenting in patients with Turner syndrome

Objectives This study examines the outcome and procedural outcomes of percutaneous stent angioplasty for aortic coarctation in patients with Turner syndrome (TS). Background TS occurs in 1 in 2,500 live‐born females and is associated with aortic coarctation. Methods In this multicenter, retrospective cohort study, all patients with TS and a coarctation of the aorta, treated with percutaneous stent implantation were included. The procedural strategies were dictated by local protocols. Adverse events at short‐ and long‐term follow‐up and qualitative parameters concerning the stent implantation were assessed. Results In the largest study to date of TS patients receiving aortic stents, a total of 19 patients from 10 centers were included. Twelve patients were treated for native and 7 for recurrent coarctation. Age at intervention was 16.9 (7–60) years (median; min–max). The coarctation diameter increased significantly from 8.0 mm (2–12) pre‐intervention to 15.0 mm (10–19) post‐intervention (P